Literature DB >> 15681829

Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies.

Morag R Graham1, Kimmo Virtaneva, Stephen F Porcella, William T Barry, Brian B Gowen, Claire R Johnson, Fred A Wright, James M Musser.   

Abstract

The molecular basis for bacterial responses to host signals during natural infections is poorly understood. The gram-positive bacterial pathogen group A Streptococcus (GAS) causes human mucosal, skin, and life-threatening systemic infections. During the transition from a throat or skin infection to an invasive infection, GAS must adapt to changing environments and host factors. To better understand how GAS adapts, we used transcript profiling and functional analysis to investigate the transcriptome of a wild-type serotype M1 GAS strain in human blood. Global changes in GAS gene expression occur rapidly in response to human blood exposure. Increased transcription was observed for many genes that likely enhance bacterial survival, including those encoding superantigens and host-evasion proteins regulated by a multiple gene activator called Mga. GAS also coordinately expressed genes involved in proteolysis, transport, and catabolism of oligopeptides to obtain amino acids in this protein-rich host environment. Comparison of the transcriptome of the wild-type strain to that of an isogenic deletion mutant (DeltacovR) mutated in the two-component regulatory system designated CovR-CovS reinforced the hypothesis that CovR-CovS has an important role linking key biosynthetic, catabolic, and virulence functions during transcriptome restructuring. Taken together, the data provide crucial insights into strategies used by pathogenic bacteria for thwarting host defenses and surviving in human blood.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681829      PMCID: PMC1602339          DOI: 10.1016/S0002-9440(10)62268-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

Review 1.  Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions.

Authors:  Bernd Kreikemeyer; Kevin S McIver; Andreas Podbielski
Journal:  Trends Microbiol       Date:  2003-05       Impact factor: 17.079

2.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B.

Authors:  A Heath; V J DiRita; N L Barg; N C Engleberg
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense.

Authors:  Jovanka M Voyich; Kevin R Braughton; Daniel E Sturdevant; Cuong Vuong; Scott D Kobayashi; Stephen F Porcella; Michael Otto; James M Musser; Frank R DeLeo
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

5.  Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.

Authors:  Ramy K Aziz; Michael J Pabst; Arthur Jeng; Rita Kansal; Donald E Low; Victor Nizet; Malak Kotb
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

6.  CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes.

Authors:  Tracy L Dalton; June R Scott
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

7.  M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.

Authors:  Heiko Herwald; Henning Cramer; Matthias Mörgelin; Wayne Russell; Ulla Sollenberg; Anna Norrby-Teglund; Hans Flodgaard; Lennart Lindbom; Lars Björck
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

8.  Comparative analysis of gene expression among low G+C gram-positive genomes.

Authors:  Samuel Karlin; Julie Theriot; Jan Mrázek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

Review 9.  Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience.

Authors:  M Kotb; A Norrby-Teglund; A McGeer; K Green; D E Low
Journal:  Scand J Infect Dis       Date:  2003

10.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

View more
  84 in total

1.  Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus.

Authors:  Stephen B Beres; Ellen W Richter; Michal J Nagiec; Paul Sumby; Stephen F Porcella; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Distinct time-resolved roles for two catabolite-sensing pathways during Streptococcus pyogenes infection.

Authors:  Colin C Kietzman; Michael G Caparon
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection.

Authors:  Jessica S Hoff; Mark DeWald; Steve L Moseley; Carleen M Collins; Jovanka M Voyich
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

4.  SpyA is a membrane-bound ADP-ribosyltransferase of Streptococcus pyogenes which modifies a streptococcal peptide, SpyB.

Authors:  Natalia Korotkova; Jessica S Hoff; Devon M Becker; John Kyle Heggen Quinn; Laura M Icenogle; Steve L Moseley
Journal:  Mol Microbiol       Date:  2012-01-30       Impact factor: 3.501

Review 5.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.

Authors:  James M Musser; Frank R DeLeo
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

6.  Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.

Authors:  Jason E Comer; Daniel E Sturdevant; Aaron B Carmody; Kimmo Virtaneva; Donald Gardner; Dan Long; Rebecca Rosenke; Stephen F Porcella; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

7.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

8.  Streptococcus pyogenes CovRS mediates growth in iron starvation and in the presence of the human cationic antimicrobial peptide LL-37.

Authors:  Barbara J Froehlich; Christopher Bates; June R Scott
Journal:  J Bacteriol       Date:  2008-11-07       Impact factor: 3.490

9.  Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.

Authors:  Nicole M Mackey-Lawrence; Xiaoti Guo; Daniel E Sturdevant; Kimmo Virtaneva; Matthew M Hernandez; Eric Houpt; Alan Sher; Stephen F Porcella; William A Petri
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.

Authors:  David E Greenberg; Stephen F Porcella; Adrian M Zelazny; Kimmo Virtaneva; Dan E Sturdevant; John J Kupko; Kent D Barbian; Amenah Babar; David W Dorward; Steven M Holland
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.